Drugs Containing Excipient (Inactive Ingredient) 2-HYDROXYETHYL METHACRYLATE

Branded drugs containing 2-HYDROXYETHYL METHACRYLATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	2-HYDROXYETHYL METHACRYLATE	2026-06-16
Endo Pharmaceuticals Inc	VANTAS	histrelin acetate	67979-500	2-HYDROXYETHYL METHACRYLATE

Generic drugs containing 2-HYDROXYETHYL METHACRYLATE excipient

Company	Ingredient	NDC	Excipient
ENDO USA Inc	histrelin acetate	67979-002	2-HYDROXYETHYL METHACRYLATE
Endo Pharmaceuticals Inc	histrelin acetate	67979-500	2-HYDROXYETHYL METHACRYLATE

Market Overview and Financial Outlook for 2-Hydroxyethyl Methacrylate (HEMA)

Last updated: February 6, 2026

2-Hydroxyethyl methacrylate (HEMA) is a key monomer used primarily in dental materials, contact lenses, adhesives, and coatings. The compound's demand correlates closely with the growth of these sectors, which influence market size, pricing, and investment prospects.

---

What Are the Main Drivers of Market Growth for HEMA?

Dental Applications: The dental industry accounts for approximately 50% of HEMA consumption due to its use in denture processing materials, composites, and adhesives. The global dental market's expansion, driven by aging populations and increasing oral health awareness, propels demand for HEMA-based products. The dental products market is projected to grow at a CAGR of 4.2% from 2022 to 2027, according to Market Research Future [1].

Contact Lenses and Ophthalmic Devices: HEMA is integral in soft contact lenses and ocular adhesives. The contact lens market is expanding by about 5% annually, underpinned by technological advances and rising eye health awareness.

Adhesives and Coatings: HEMA-based polymers are used for their hydrophilic nature. The adhesives segment is expected to grow at a CAGR of 3.8% over the next five years, supported by increased industrial and packaging applications.

Emerging Trends: The development of HEMA-free alternatives, advances in photo-crosslinking techniques, and rising regulatory scrutiny for biomedical materials impact the market. Adoption of sustainable synthesis methods also gains traction.

---

How Is the Market Structured?

Segment	Contribution to Global HEMA Market (2022)	Growth Outlook (Next 5 Years)
Dental	50%	CAGR 4.2%
Contact Lenses	25%	CAGR 5.0%
Adhesives & Coatings	15%	CAGR 3.8%
Others	10%	Variable, dependent on biomedical R&D

Major manufacturers include Evonik Industries, Nippon Shokubai, and SACHEM, dominating regional supplies with focus on quality and regulatory compliance.

---

What Are the Key Market Challenges?

Raw Material Price Volatility: The acrylic acid and methacrylate monomer markets fluctuate based on feedstock costs, impacting HEMA prices.

Regulatory Environment: Tightening regulations on biomedical materials and chemicals necessitate rigorous safety testing, increasing R&D costs.

Environmental Concerns: Sustainability concerns prompt research into greener synthesis pathways, potentially affecting traditional manufacturing processes.

---

What Is the Financial Trajectory?

Revenue Projections: The global HEMA market was valued at approximately $150 million in 2022. It is expected to reach $210 million by 2027, with a CAGR around 6.0%.

Profit Margins: Operating margins for HEMA suppliers range between 15-25%, influenced by economies of scale, feedstock costs, and regulatory compliance costs.

Investment Trends: R&D investments are focused on developing HEMA derivatives, bio-based alternatives, and process improvements. Public and private sector funding in biomedical applications increases with regulatory approval timelines.

Pricing Trends: Prices for commercial-grade HEMA have seen a compound annual decline of approximately 2% over the last five years, driven by manufacturing efficiencies and competitive pressures.

---

What Are Future Opportunities?

• Development of bio-based HEMA and alternatives to reduce environmental impact.
• Expansion into emerging markets in Asia-Pacific, which anticipates higher growth rates (CAGR 5.0-6.0%) due to expanding dental and ophthalmic sectors.
• Innovation in crosslinking technologies to improve product performance, opening new application avenues.

---

Summary of Market Risks

• Volatility in feedstock markets affects profitability.
• Regulatory changes may extend development timelines.
• Further adoption of HEMA-free materials may reduce demand.

---

Key Takeaways

• HEMA's market depends heavily on dental and contact lens sectors.
• The industry is projected to grow at a 6.0% CAGR, reaching around $210 million globally by 2027.
• Pricing remains under pressure due to manufacturing efficiencies, but investments in R&D and environmental sustainability are shaping future growth.
• Regional expansion, especially in Asia-Pacific, offers long-term opportunities.
• Manufacturers face risks from raw material volatility, regulatory barriers, and shifting industry preferences.

---

FAQs

1. What are the primary applications of HEMA?
Dental materials, contact lenses, adhesives, and coatings.

2. How does market growth vary regionally?
Higher growth in Asia-Pacific (CAGR 5.0-6.0%) compared to North America and Europe, driven by expanding dental and ophthalmic markets.

3. What are the main cost factors influencing HEMA production?
Feedstock prices (acrylic acid, methacrylate monomers), energy, and compliance costs.

4. Are there regulatory hurdles specific to HEMA?
Yes, especially in biomedical applications, requiring safety testing and compliance with ISO, FDA, and EMA standards.

5. What technological innovations are impacting the market?
Bio-based synthesis pathways, HEMA-free formulations, and advanced crosslinking technologies.

---

References

[1] Market Research Future, "Dental Market Analysis," 2022.